In line with the deleterious pro-inflammatory role of Ang II in CHF, pharmacological blockade of the AT1 receptors in this clinical setting decreased the levels of pro-inflammatory cytokines including TNF-α (78, 79). The gene discussed is AGT; the disease is congestive heart failure.